1. Homozygous deletions implicate non-coding epigenetic marks in Autism spectrum disorder
- Author
-
Anh Thu N. Lam, Sarah Servattalab, Michael E. Greenberg, R. Sean Hill, Bhaven K. Mehta, Timothy W. Yu, Guzman Sanchez-Schmitz, Kyriacos Markianos, Klaus Schmitz-Abe, Ryan N. Doan, Maria H. Chahrour, Bulent Ataman, Christopher A. Walsh, and Eric M. Morrow
- Subjects
0301 basic medicine ,Male ,DNA Copy Number Variations ,Autism Spectrum Disorder ,lcsh:Medicine ,Biology ,ENCODE ,Article ,Epigenesis, Genetic ,03 medical and health sciences ,Exon ,0302 clinical medicine ,mental disorders ,medicine ,Humans ,Genetic Predisposition to Disease ,Copy-number variation ,Epigenetics ,lcsh:Science ,Epigenomics ,Regulation of gene expression ,Genetics ,Multidisciplinary ,Homozygote ,lcsh:R ,medicine.disease ,Gene regulation ,030104 developmental biology ,Autism spectrum disorder ,Computational neuroscience ,Human genome ,Female ,lcsh:Q ,030217 neurology & neurosurgery ,Gene Deletion - Abstract
More than 98% of the human genome is made up of non-coding DNA, but techniques to ascertain its contribution to human disease have lagged far behind our understanding of protein coding variations. Autism spectrum disorder (ASD) has been mostly associated with coding variations via de novo single nucleotide variants (SNVs), recessive/homozygous SNVs, or de novo copy number variants (CNVs); however, most ASD cases continue to lack a genetic diagnosis. We analyzed 187 consanguineous ASD families for biallelic CNVs. Recessive deletions were significantly enriched in affected individuals relative to their unaffected siblings (17% versus 4%, p p
- Published
- 2020
- Full Text
- View/download PDF